Dozens of commonly prescribed medications can darken the skin, and drug-induced pigmentation accounts for roughly 10 to 20 percent of all cases of acquired hyperpigmentation.1PubMed. Drug-induced skin pigmentation: Epidemiology, diagnosis and treatment The color change can be brown, blue-gray, or even slate-black depending on the drug involved, and it shows up most often on sun-exposed areas like the face, neck, and hands. Some of the biggest offenders are medications people take for years, including certain antibiotics, heart drugs, antimalarials, chemotherapy agents, and psychiatric medications.
How Drugs Change Skin Color
There is no single mechanism behind drug-induced skin darkening. The pathway depends on the specific medication, but most cases fall into a few broad categories. The most common route is an increase in melanin, the pigment your skin already produces. Some drugs trigger low-grade inflammation in the skin, which in turn ramps up melanin production, and sun exposure tends to make this worse. Other drugs physically accumulate in the skin themselves, depositing their own color. A third pathway involves the drug stimulating the body to produce unusual pigments it would not normally make. And in some cases, drugs damage small blood vessels in the skin, releasing iron from red blood cells, which stains the surrounding tissue.2PubMed. Drug-Induced Pigmentation: A Review Many drugs involve more than one of these processes at once, which is part of what makes the resulting color changes so variable from person to person.
Antibiotics and Antimalarials
Tetracycline antibiotics are among the most recognized culprits, and minocycline stands out in particular. People who take minocycline for extended periods, often for acne, can develop blue-gray patches on the skin. The discoloration tends to appear on the shins, forearms, or in old acne scars, and it results from iron-containing metabolites of the drug depositing in the dermis.3PubMed Central. Minocycline-induced cutaneous hyperpigmentation The color can be alarming because it looks nothing like a typical tan; it often has a distinctly blue or slate hue that is more noticeable in lighter skin.
Hydroxychloroquine, widely used for lupus and rheumatoid arthritis, is another long-term medication linked to skin darkening. The pigmentation usually appears as brown or blue-gray patches, frequently on the shins or in areas already affected by bruising. The discoloration is thought to involve both melanin accumulation and the drug itself binding to tissue. Because hydroxychloroquine is often prescribed for conditions that already cause skin changes, the drug-induced color shifts can be mistaken for disease progression if a clinician is not looking for them.4PubMed Central. Hydroxychloroquine-related skin discoloration
Heart Medications
Amiodarone, a powerful drug used to control irregular heart rhythms, is notorious for turning sun-exposed skin a distinctive blue-gray. For decades, dermatologists assumed this color came from a waste pigment called lipofuscin building up in the skin. More recent analysis using electron microscopy and chemical identification found that the hyperpigmented skin actually contained amiodarone deposits themselves, challenging the older explanation.5JAMA Dermatology. Photodistribution of Blue-Gray Hyperpigmentation After Amiodarone Treatment: Molecular Characterization of Amiodarone in the Skin The practical implication is that the drug accumulates physically in skin tissue, which helps explain why the discoloration is strongly concentrated in areas that get the most sunlight. The color change typically appears after months of use and can persist long after the drug is discontinued because amiodarone has an extraordinarily long half-life and clears the body slowly.
Chemotherapy and Cancer Drugs
A wide range of chemotherapy agents darken the skin, and the patterns vary depending on the specific drug. Alkylating agents like cyclophosphamide, ifosfamide, and thiotepa are known to cause hyperpigmentation, sometimes in the nails, sometimes diffusely across the body.6PubMed. Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. Conventional chemotherapeutic drugs Bleomycin, used for certain lymphomas and germ-cell tumors, can produce a striking pattern called flagellate hyperpigmentation, where dark streaks appear along the lines where the drug was infused or along scratch marks. The darkening from chemotherapy often develops quickly, sometimes within weeks of starting treatment, and can affect the nails as dark bands running lengthwise along the nail plate.
Newer targeted cancer therapies add another layer of complexity. Imatinib, a tyrosine kinase inhibitor used for chronic myeloid leukemia, is more commonly associated with lightening the skin. But in some patients the opposite happens, with extensive darkening developing during treatment.7PubMed Central. Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia This unpredictability highlights a recurring theme in drug-induced pigmentation: the same medication can push skin color in different directions depending on the patient’s genetics, baseline pigmentation, and dose.
Psychiatric Medications
Chlorpromazine, one of the earliest antipsychotic drugs, has been linked to skin darkening since the 1960s. Patients who take it for years can develop a purplish pigmentation on sun-exposed areas of the face, neck, and hands.8PubMed Central. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY. Tissue samples from affected skin show melanin-like material deposited in the upper layers of the dermis, particularly around blood vessels. In addition to skin changes, prolonged chlorpromazine use can cause pigmentation of the cornea and lens of the eye, sometimes visible as a brownish haze.9PubMed. Chlorpromazine-induced skin pigmentation with corneal and lens opacities While chlorpromazine is less commonly prescribed today than it once was, other phenothiazine antipsychotics can cause similar effects. The risk increases with cumulative dose and with sun exposure, so the darkening tends to appear on areas the patient cannot easily cover.
Hormonal Therapies and Oral Contraceptives
Hormonal medications are a major cause of melasma, the tan or brown patches that typically appear on the cheeks, forehead, upper lip, and chin. Oral contraceptives are the best-studied trigger. In studies of women taking oral contraceptives, roughly a quarter to nearly a third developed melasma.10PubMed Central. Melasma and other skin manifestations or oral contraceptives The estrogen and progesterone in these pills stimulate melanocytes to produce more pigment, and the effect is amplified by sun exposure. Melasma from hormonal medications can be slow to fade, sometimes lingering for months or years after stopping the pill. Hormone replacement therapy used during menopause can trigger the same kind of pigmentation, though it is somewhat less common than with oral contraceptives. Pregnancy itself causes the identical pattern through the same hormonal mechanism, which is why melasma is sometimes called “the mask of pregnancy.”
Glaucoma Eye Drops
If you use prostaglandin analog eye drops for glaucoma, you may have noticed darkening of the skin around your eyes. Bimatoprost, one of the most widely prescribed glaucoma drops, causes periocular skin hyperpigmentation that develops gradually. In one clinical series, the color change was completely reversible when the drug was stopped.11PubMed. Clinical course of bimatoprost-induced periocular skin changes in Caucasians Latanoprost, another prostaglandin analog, does the same thing, with the eyelid darkening similarly fading after the drops are discontinued.12PubMed. Increased eyelid pigmentation associated with use of latanoprost These drugs stimulate melanin production locally, which is also why they can permanently darken the iris in people with lighter-colored eyes. The skin darkening around the eyelids tends to be most obvious in lighter-skinned patients and can look like a persistent dark circle. The fact that it reverses when the drops are stopped makes it one of the more forgiving forms of drug-induced pigmentation.
Psoralens and Phototherapy
Some drugs are deliberately used to darken the skin. Psoralens are plant-derived compounds that, when combined with long-wave ultraviolet light (a regimen called PUVA therapy), stimulate the skin to produce pigment.13PubMed. Psoralen phototherapy and phototoxicity PUVA therapy has been used for decades to treat vitiligo, the condition where patches of skin lose their color. Psoralens work by binding to DNA in melanocytes when activated by ultraviolet light, triggering the melanocytes to divide, produce more pigment-carrying structures, and transfer that pigment to surrounding skin cells.14PubMed. Photochemotherapy (PUVA) in psoriasis and vitiligo The skin darkening from PUVA is intentional and therapeutic, but it can overshoot, leaving treated areas darker than the surrounding skin if the dose or exposure time is not carefully calibrated.
Afamelanotide works through a different approach. It is a synthetic version of a hormone your body naturally produces to stimulate melanin. By binding to the melanocortin-1 receptor on melanocytes, it boosts production of eumelanin, the darker, more photoprotective form of melanin.15PubMed Central. Afamelanotide in protoporphyria and other skin diseases: a review It is used as an implant for patients with erythropoietic protoporphyria, a condition that makes sunlight excruciatingly painful. By increasing melanin, afamelanotide gives these patients a layer of natural sun protection they would otherwise lack.
Silver and Heavy Metals
Silver-containing preparations occupy a unique category because the skin changes they produce are often permanent. Argyria is the medical term for the blue-gray discoloration caused by silver accumulation in the skin, and it has been documented repeatedly in people who ingest colloidal silver as an alternative health remedy.16PubMed Central. A case of argyria following colloidal silver ingestion The discoloration is most visible on the face and hands and has been described as slate-gray. Unlike most other forms of drug-induced pigmentation, argyria is considered irreversible because the silver particles become permanently embedded in the skin’s structure.17PubMed. Argyria Induced by Prolonged Ingestion of Silver Ionized Water Silver nitrate applied topically, once common for wound care, can produce the same effect locally.18PubMed Central. Argyria after Silver Nitrate Intake: Case Report and Brief Review of Literature
Gold compounds, once used for rheumatoid arthritis, can cause a similar but rarer condition called chrysiasis, producing a gray or purplish hue. Bismuth, the active ingredient in some over-the-counter stomach remedies, can darken the tongue and gums but rarely causes widespread skin changes at typical doses. The common thread with heavy metals is that the metal ions physically deposit in tissue, and once there, they are very difficult to remove.
The Melanotan Underground
Outside the clinical world, unregulated peptides marketed as tanning aids represent a growing concern. Melanotan I and Melanotan II are synthetic melanocortin analogs sold online and self-injected by people who want a deeper tan without prolonged sun exposure. Melanotan II in particular has been linked to widespread skin darkening along with the appearance of new or darkened moles. In one documented case, a teenage girl developed general skin tanning and multiple darkened moles after self-injecting Melanotan II and using UV tanning beds.19PubMed Central. Changes of melanocytic lesions induced by Melanotan injections and sun bed use in a teenage patient with FAMMM syndrome The worry is not just cosmetic. These peptides stimulate melanocyte activity broadly and may promote changes in existing moles, making it harder to detect melanoma on skin exams. Melanotan products are not approved by any major regulatory body and are manufactured without quality controls, so users have no way to verify the dose or purity of what they are injecting.
Which Drugs Are Most Likely to Cause Darkening
The drugs most frequently implicated in skin pigmentation are non-steroidal anti-inflammatory drugs (NSAIDs), antimalarials, amiodarone, cytotoxic chemotherapy agents, tetracycline antibiotics, heavy metals, and psychotropic medications.1PubMed. Drug-induced skin pigmentation: Epidemiology, diagnosis and treatment NSAIDs may come as a surprise on this list, since millions of people take ibuprofen and naproxen without any skin changes. But in uncommon cases, particularly with long-term use and sun exposure, NSAIDs can produce fixed drug eruptions that leave behind darkened patches after the inflammation subsides. These patches recur in the exact same spot each time the drug is taken, which is actually one of the most useful diagnostic clues for drug-induced pigmentation in general.
The risk is not equal across all skin types. People with darker baseline skin tones sometimes develop more noticeable hyperpigmentation because their melanocytes are more reactive. Conversely, the blue-gray discoloration from drugs like amiodarone or minocycline tends to be most visually striking in lighter-skinned individuals. Sun exposure amplifies most forms of drug-induced pigmentation regardless of skin type, because ultraviolet radiation drives melanin production and can also accelerate the photochemical reactions that create drug-derived pigments.
How Drug-Induced Darkening Is Identified
When unexplained skin darkening appears, especially in an older adult taking multiple medications, drug-induced pigmentation should be high on the list of possibilities. Clinicians typically look at the color and distribution of the changes for clues. Brown pigmentation that follows sun-exposed patterns suggests melanin accumulation. Blue-gray discoloration, particularly in a photo-distributed pattern, points toward drug or iron deposits in the dermis.
When the clinical picture is ambiguous, a skin biopsy can help distinguish between causes. Special staining techniques identify what kind of pigment is present. Fontana-Masson staining highlights melanin and melanin-like pigments, while Perls’ Prussian blue stain picks up iron. In minocycline pigmentation, for example, biopsy samples often stain positive for both melanin and iron, reflecting the dual deposition mechanism. Different drugs produce distinctive histological patterns in terms of where the pigment sits within the skin layers and which structures it surrounds.20Journal of Vascular Surgery Cases, Innovations and Techniques. Drug-induced hyperpigmentation confounding clinical assessment and management for advanced chronic venous insufficiency Getting the diagnosis right matters because it prevents unnecessary workups for other causes of skin darkening, such as Addison’s disease or hemochromatosis, and it guides the decision about whether the medication needs to be changed.
Does the Darkening Go Away
The reversibility of drug-induced pigmentation varies enormously. When the mechanism is increased melanin production, as with oral contraceptives or glaucoma drops, the darkening usually fades over weeks to months after the drug is stopped, though fading can be slow and incomplete. Melanin in the upper layers of the skin turns over as skin cells naturally shed, but melanin that has been pushed deeper into the dermis is picked up by immune cells called macrophages, which can hold onto it for much longer.
When the drug itself has been deposited in the skin, as with amiodarone or minocycline, clearance depends on how fast the body can metabolize and remove those deposits. Amiodarone pigmentation can take a year or more to fade because the drug accumulates in fat tissue and has a half-life measured in months. Silver deposits, on the other hand, are essentially permanent. Argyria does not resolve because the body has no efficient mechanism for clearing elemental silver from dermal tissue.
For anyone dealing with drug-induced skin darkening, the first conversation should be with the prescribing clinician about whether the medication can be substituted. In many cases, an equally effective alternative exists that does not carry the same pigmentation risk. Strict sun protection, including broad-spectrum sunscreen and protective clothing, can slow the progression and sometimes hasten the resolution of melanin-driven discoloration. Topical lightening agents like hydroquinone or azelaic acid are sometimes used to speed fading of melanin-based hyperpigmentation, but they are ineffective against pigment caused by drug deposits or iron. Laser treatments have shown some promise for certain types of drug-induced pigmentation, particularly minocycline-related discoloration, though results are inconsistent and the evidence base remains small.
When Drug-Induced Pigmentation Mimics Other Conditions
One of the practical dangers of drug-induced skin darkening is that it can be mistaken for something more serious, or it can mask something that is. Diffuse skin darkening can mimic Addison’s disease, a condition where the adrenal glands fail and the body overproduces melanocyte-stimulating hormone. Blue-gray patches on the legs can look like venous stasis changes or bruising in older adults. In patients on chemotherapy, new pigmented lesions can raise concern about melanoma. A careful medication history is often the single most useful tool: if the timing of the color change aligns with starting a new drug, and if the pattern matches what that drug is known to produce, the diagnosis usually becomes clear without invasive testing. The complication arises when patients are on several medications simultaneously, making it harder to identify which one is responsible. In those situations, systematic withdrawal of one drug at a time, when clinically safe, is sometimes the only way to pin down the cause.